Clinically, OSA patients exhibit elevated gut permeability biomarkers (e.g., D‐lactate, I‐FABP) correlating with the abundance of pro‐inflammatory taxa and the depletion of beneficial SCFA‐producing bacteria [36]. The gene discussed is FABP2; the disease is obstructive sleep apnea syndrome.